Pneumatic Nebulizers Market Size & Share 2021 to 2027
Market Size by Product (Vented {Tabletop, Portable}, Breath-Actuated {Tabletop, Portable}) & Forecast.Download Free PDF
Report Content
Chapter 1 Methodology
1.1 Market definitions
1.2 Base estimates & working
1.3 Forecast parameters
1.4 Data validation
1.5 Data Sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Pneumatic nebulizers market industry 3600 synopsis, 2016 - 2027
2.1.1 Business trends
2.1.2 Product trends
2.1.3 Regional trends
Chapter 3 Pneumatic Nebulizers Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2016 - 2027
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Rising adoption of minimally invasive surgical procedures
3.3.1.2 Increasing number of lifestyle disorders in developing economies
3.3.1.3 Various reimbursement policies in developed economies
3.3.1.4 Growing geriatric population base across the globe
3.3.2 Industry pitfalls & challenges
3.3.2.1 High cost of pneumatic nebulizers
3.3.2.2 Dearth of skilled healthcare professionals in developing economies
3.4 Growth potential analysis
3.4.1 By product
3.5 COVID-19 impact analysis
3.6 Product landscape
3.7 Regulatory scenario
3.8 Porter's analysis
3.9 Competitive landscape, 2020
3.9.1 Company matrix analysis
3.10 PESTEL analysis
Chapter 4 Pneumatic Nebulizers Market, By Product
4.1 Key segment trends
4.2 Vented pneumatic nebulizers
4.2.1 Market size, by region, 2016 – 2027 (USD Million)
4.2.2 Table-top vented pneumatic nebulizers
4.2.2.1 Market size, by region, 2016 – 2027 (USD Million)
4.2.3 Portable vented pneumatic nebulizers
4.2.3.1 Market size, by region, 2016 – 2027 (USD Million)
4.3 Breath-actuated pneumatic nebulizers
4.3.1 Market size, by region, 2016 – 2027 (USD Million)
4.3.2 Table-top vented pneumatic nebulizers
4.3.2.1 Market size, by region, 2016 – 2027 (USD Million)
4.3.3 Portable vented pneumatic nebulizers
4.3.3.1 Market size, by region, 2016 – 2027 (USD Million)
Chapter 5 Pneumatic Nebulizers Market, By Region
5.1 Key regional trends
5.2 North America
5.2.1 Market size, by country, 2016 - 2027 (USD Million)
5.2.2 Market size, by product, 2016 - 2027 (USD Million)
5.2.2.1 Market size, by vented pneumatic nebulizers, 2016 - 2027 (USD Million)
5.2.2.2 Market size, by breath-actuated pneumatic nebulizers, 2016 - 2027 (USD Million)
5.2.3 U.S.
5.2.3.1 Market size, by product, 2016 - 2027 (USD Million)
5.2.3.1.1 Market size, by vented pneumatic nebulizers, 2016 - 2027 (USD Million)
5.2.3.1.2 Market size, by breath-actuated pneumatic nebulizers, 2016 - 2027 (USD Million)
5.2.4 Canada
5.2.4.1 Market size, by product, 2016 - 2027 (USD Million)
5.2.4.1.1 Market size, by vented pneumatic nebulizers, 2016 - 2027 (USD Million)
5.2.4.1.2 Market size, by breath-actuated pneumatic nebulizers, 2016 - 2027 (USD Million)
5.3 Europe
5.3.1 Market size, by country, 2016 - 2027 (USD Million)
5.3.2 Market size, by product, 2016 - 2027 (USD Million)
5.3.2.1 Market size, by vented pneumatic nebulizers, 2016 - 2027 (USD Million)
5.3.2.2 Market size, by breath-actuated pneumatic nebulizers, 2016 - 2027 (USD Million)
5.3.3 Germany
5.3.3.1 Market size, by product, 2016 - 2027 (USD Million)
5.3.3.1.1 Market size, by vented pneumatic nebulizers, 2016 - 2027 (USD Million)
5.3.3.1.2 Market size, by breath-actuated pneumatic nebulizers, 2016 - 2027 (USD Million)
5.3.4 UK
5.3.4.1 Market size, by product, 2016 - 2027 (USD Million)
5.3.4.1.1 Market size, by vented pneumatic nebulizers, 2016 - 2027 (USD Million)
5.3.4.1.2 Market size, by breath-actuated pneumatic nebulizers, 2016 - 2027 (USD Million)
5.3.5 France
5.3.5.1 Market size, by product, 2016 - 2027 (USD Million)
5.3.5.1.1 Market size, by vented pneumatic nebulizers, 2016 - 2027 (USD Million)
5.3.5.1.2 Market size, by breath-actuated pneumatic nebulizers, 2016 - 2027 (USD Million)
5.3.6 Spain
5.3.6.1 Market size, by product, 2016 - 2027 (USD Million)
5.3.6.1.1 Market size, by vented pneumatic nebulizers, 2016 - 2027 (USD Million)
5.3.6.1.2 Market size, by breath-actuated pneumatic nebulizers, 2016 - 2027 (USD Million)
5.3.7 Italy
5.3.7.1 Market size, by product, 2016 - 2027 (USD Million)
5.3.7.1.1 Market size, by vented pneumatic nebulizers, 2016 - 2027 (USD Million)
5.3.7.1.2 Market size, by breath-actuated pneumatic nebulizers, 2016 - 2027 (USD Million)
5.4 Asia Pacific
5.4.1 Market size, by country, 2016 - 2027 (USD Million)
5.4.2 Market size, by product, 2016 - 2027 (USD Million)
5.4.2.1 Market size, by vented pneumatic nebulizers, 2016 - 2027 (USD Million)
5.4.2.2 Market size, by breath-actuated pneumatic nebulizers, 2016 - 2027 (USD Million)
5.4.3 Japan
5.4.3.1 Market size, by product, 2016 - 2027 (USD Million)
5.4.3.1.1 Market size, by vented pneumatic nebulizers, 2016 - 2027 (USD Million)
5.4.3.1.2 Market size, by breath-actuated pneumatic nebulizers, 2016 - 2027 (USD Million)
5.4.4 China
5.4.4.1 Market size, by product, 2016 - 2027 (USD Million)
5.4.4.1.1 Market size, by vented pneumatic nebulizers, 2016 - 2027 (USD Million)
5.4.4.1.2 Market size, by breath-actuated pneumatic nebulizers, 2016 - 2027 (USD Million)
5.4.5 India
5.4.5.1 Market size, by product, 2016 - 2027 (USD Million)
5.4.5.1.1 Market size, by vented pneumatic nebulizers, 2016 - 2027 (USD Million)
5.4.5.1.2 Market size, by breath-actuated pneumatic nebulizers, 2016 - 2027 (USD Million)
5.4.6 Australia
5.4.6.1 Market size, by product, 2016 - 2027 (USD Million)
5.4.6.1.1 Market size, by vented pneumatic nebulizers, 2016 - 2027 (USD Million)
5.4.6.1.2 Market size, by breath-actuated pneumatic nebulizers, 2016 - 2027 (USD Million)
5.5 Latin America
5.5.1 Market size, by country, 2016 - 2027 (USD Million)
5.5.2 Market size, by product, 2016 - 2027 (USD Million)
5.5.2.1 Market size, by vented pneumatic nebulizers, 2016 - 2027 (USD Million)
5.5.2.2 Market size, by breath-actuated pneumatic nebulizers, 2016 - 2027 (USD Million)
5.5.3 Brazil
5.5.3.1 Market size, by product, 2016 - 2027 (USD Million)
5.5.3.1.1 Market size, by vented pneumatic nebulizers, 2016 - 2027 (USD Million)
5.5.3.1.2 Market size, by breath-actuated pneumatic nebulizers, 2016 - 2027 (USD Million)
5.5.4 Mexico
5.5.4.1 Market size, by product, 2016 - 2027 (USD Million)
5.5.4.1.1 Market size, by vented pneumatic nebulizers, 2016 - 2027 (USD Million)
5.5.4.1.2 Market size, by breath-actuated pneumatic nebulizers, 2016 - 2027 (USD Million)
5.6 Middle East & Africa
5.6.1 Market size, by country, 2016 - 2027 (USD Million)
5.6.2 Market size, by product, 2016 - 2027 (USD Million)
5.6.2.1 Market size, by vented pneumatic nebulizers, 2016 - 2027 (USD Million)
5.6.2.2 Market size, by breath-actuated pneumatic nebulizers, 2016 - 2027 (USD Million)
5.6.3 South Africa
5.6.3.1 Market size, by product, 2016 - 2027 (USD Million)
5.6.3.1.1 Market size, by vented pneumatic nebulizers, 2016 - 2027 (USD Million)
5.6.3.1.2 Market size, by breath-actuated pneumatic nebulizers, 2016 - 2027 (USD Million)
5.6.4 Saudi Arabia
5.6.4.1 Market size, by product, 2016 - 2027 (USD Million)
5.6.4.1.1 Market size, by vented pneumatic nebulizers, 2016 - 2027 (USD Million)
5.6.4.1.2 Market size, by breath-actuated pneumatic nebulizers, 2016 - 2027 (USD Million)
Chapter 6 Company Profiles
6.1 Competitive dashboard
6.2 Aerogen Limited
6.2.1 Business overview
6.2.2 Financial data
6.2.3 Product landscape
6.2.4 Strategic outlook
6.2.5 SWOT analysis
6.3 Allied Healthcare Products, Inc.
6.3.1 Business overview
6.3.2 Financial data
6.3.3 Product landscape
6.3.4 Strategic outlook
6.3.5 SWOT analysis
6.4 Briggs Healthcare
6.4.1 Business overview
6.4.2 Financial data
6.4.3 Product landscape
6.4.4 Strategic outlook
6.4.5 SWOT analysis
6.5 Becton, Dickinson and Company
6.5.1 Business overview
6.5.2 Financial data
6.5.3 Product landscape
6.5.4 Strategic outlook
6.5.5 SWOT analysis
6.6 Heyer Medical AG
6.6.1 Business overview
6.6.2 Financial data
6.6.3 Product landscape
6.6.4 Strategic outlook
6.6.5 SWOT analysis
6.7 OMRON Corporation
6.7.1 Business overview
6.7.2 Financial data
6.7.3 Product landscape
6.7.4 Strategic outlook
6.7.5 SWOT analysis
6.8 PARI Medical Holdings GmbH
6.8.1 Business overview
6.8.2 Financial data
6.8.3 Product landscape
6.8.4 Strategic outlook
6.8.5 SWOT analysis
6.9 Philips Respironics, Inc.
6.9.1 Business overview
6.9.2 Financial data
6.9.3 Product landscape
6.9.4 Strategic outlook
6.9.5 SWOT analysis
6.10 Salter Labs
6.10.1 Business overview
6.10.2 Financial data
6.10.3 Product landscape
6.10.4 Strategic outlook
6.10.5 SWOT analysis
6.11 TaiDoc Technology
6.11.1 Business overview
6.11.2 Financial data
6.11.3 Product landscape
6.11.4 Strategic outlook
6.11.5 SWOT analysis
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at [email protected]
Base Year: 2020
Companies covered: 10
Tables & Figures: 159
Countries covered: 15
Pages: 150
Download Free PDF
Base Year: 2020
Companies covered: 10
Tables & Figures: 159
Countries covered: 15
Pages: 150
Download Free PDF
Share Content
Add Citations
Mariam Faizullabhoy. 2021, August. Pneumatic Nebulizers Market - By Product (Vented {Tabletop, Portable}, Breath-Actuated {Tabletop, Portable}) & Forecast, 2021-2027 (Report ID: GMI625). Global Market Insights Inc. Retrieved March 28, 2026, from https://www.gminsights.com/toc/details/pneumatic-nebulizers-market
Pneumatic Nebulizers Market
Get a free sample of this report
Pneumatic Nebulizers Market Size
Pneumatic Nebulizers Market size exceeded USD 557.7 million in 2020 and is anticipated to grow at over 5.2% CAGR between 2021 and 2027. The rising pervasiveness of asthma and chronic obstructive pulmonary disease will foster the market growth during the forecast timeline. The increasing incidence of respiratory defects is attributable to the growing global air pollution will further fuel the market expansion. Moreover, the growing geriatric population base across the world will spur the market value in the coming years.
The spread of the COVID-19 pandemic across the globe has positively impacted market in 2020. The medical device market witnessed a sudden spike in the sales of pneumatic nebulizers during pandemic. The outbreak of COVID-19 pandemic highlighted the need for aerosol-generating procedures such as nebulizers for the treatment of respiratory disorders and infection such as asthma, SARS-CoV-2 and others. Home-based COVID infected patients used nebulizers to get relief from the symptoms of infection. The demand barbed as the number of infection rate increased and high adoption of home-based treatment.
Pneumatic Nebulizers Market Trends
The rising prevalence of asthma and COPD (chronic obstructive pulmonary disease) diseases will propel the industry growth. According to the World Health Organization, in 2019, around 262 million people suffered from asthma and it resulted in 4,61,000 deaths globally. The treatment of asthma and COPD is long-term may result in high healthcare expenditure. Furthermore, rising urbanization, declining quality of air, and high awareness regarding respiratory disease and treatment will further stimulate the demand for pneumatic nebulizers in the industry.
Risk of infection due to the nebulizers will slow down the market progression
The American Society of Microbiology (ASM) stated that regular use of pneumatic nebulizers at home setting will increase the risks of bacterial infection. The pneumatic nebulizers devices may host the growth of pathogens like Rhizobium, Stenotrophomonas, Staphylococcus, and Streptococcus. This has been negatively impacting the market and will continue to restrain the industry expansion in the coming years. Additionally, lower insurance coverage scenarios in developing economies will further restrict the industry value during the forecast period.
Pneumatic Nebulizers Market Analysis
Breath actuated segment was valued at USD 338 million in 2020. The increasing prevalence of asthma, COPD and coronavirus infection in the geriatric population will impel the demand for pneumatic nebulizers products and drive the industry progression. Geriatric population experience various respiratory disorders such as emphysema, chronic obstructive pulmonary disease, asthma, lower respiratory infections and pulmonary hypertension. Treatment of these morbidities require inhaled therapies for that nebulizers are primary required. In addition, rising incidences of respiratory diseases and infection through the world will further boost the demand for pneumatic nebulizers in the industry.
North America pneumatic nebulizers market is expected to showcase over 4.8% growth rate through 2027 led by the growing incidence and prevalence of asthma among the population. According to Asthma and Allergy Foundation of America (AAFA), more than 25 million American people suffer from asthma which equals to one in thirteen American people. The asthma prevalence rate in children is also increasing, around 44.3% of American children (under 18 years old) has asthma. In North America, asthma is more common in adult women than men. The high prevalence of asthma will enhance the demand for aerosol therapy, thereby influencing the industry demand of pneumatic nebulizers over the forecast timeframe.
Pneumatic Nebulizers Market Share
A few key companies operating in the market are
These market leaders are focusing on numerous strategies such as acquisitions, mergers, partnerships, new product launches, and collaborations to increase their revenue share for pneumatic nebulizers.
The pneumatic nebulizers market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027, for the following segments:
Market, By Product
The above information is provided for the following regions and countries: